Semaglutide reduces the risk of heart attack, stroke, and other major cardiac events. | Drug Discovery And Development ...

Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a ...

A new analysis finds that the heart-protecting benefits of semaglutide are largely independent of its weight loss effects.

A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and ...

Even when weight doesn’t drop much, the obesity-medication semaglutide still offers major heart-protection, research shows.

Semaglutide appears to be protective against heart attacks and other cardiac events regardless of weight loss, research has ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

The number of medications in development to treat obesity continues to grow, and the drugs can offer health benefits for ...

Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much ...

More work needs to be done to tease out the mechanisms by which GLP-1 RAs lower the risk of MACE, researchers say.

Weight management medications are transforming the landscape of obesity treatment, with semaglutide emerging as a groundbreaking solution for individuals struggling with weight loss. As demand surges ...